Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adil Samad

Orthopaedic Surgery of the Spine Temple Terrace, FL Medical Doctor

NPI 1538468160 CMS profile 2780353

5901 E Fowler Ave, Temple Terrace, FL 33617

Open in the dashboard

General payments

$212,443

172 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adil Samad of Temple Terrace, FL is reported in the CMS Open Payments database as having received $212,443 across 172 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $51,285 33
2024 General $39,671 26
2023 General $37,225 25
2022 General $30,796 25
2021 General $22,935 20
2020 General $9,594 15
2019 General $20,937 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adil Samad
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Adil Samad were reported at $51,285. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Adil Samad Orthopaedic Surgery of the Spine median Middle half National median
2019 $20,937 $2,106 $337–$18,608 $163
2020 $9,594 $1,213 $156–$15,082 $114
2021 $22,935 $1,834 $271–$15,617 $132
2022 $30,796 $2,015 $320–$17,036 $149
2023 $37,225 $1,925 $336–$14,599 $160
2024 $39,671 $2,110 $341–$12,483 $164
2025 $51,285 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alphatec Spine, Inc $149,017 54 payments
  2. Linvatec Corporation $51,939 45 payments
  3. Carlsmed, Inc. $8,600 31 payments
  4. Spinal Elements, Inc. $972 9 payments
  5. Integrity Implants Inc $311 4 payments
  6. Globus Medical, Inc. $241 3 payments
  7. Innovation Technologies Inc $169 1 payment
  8. Stryker Corporation $169 5 payments
  9. Boston Scientific Corporation $165 2 payments
  10. DePuy Synthes Sales Inc. $150 1 payment
  11. Other $708 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $100,778 13 payments
  2. Consulting Fee $97,563 55 payments
  3. Travel and Lodging $9,354 23 payments
  4. Food and Beverage $4,693 80 payments
  5. Entertainment $55 1 payment
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $109,998 40 payments
  2. INSIGNIA ACP $21,815 2 payments
  3. PRESSFT $14,250 12 payments
  4. Cervical $11,280 6 payments
  5. aprevo $8,600 31 payments
  6. LINVATEC EXTREMITIES $6,000 4 payments
  7. LINVATEC ARTHROSCOPY $5,071 7 payments
  8. ACUMED $3,250 2 payments
  9. MICROPOWER $3,069 4 payments
  10. EZSTART $3,000 2 payments
  11. Other $19,917 50 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Orthopedic Surgery: 203

Drug cost

$89

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 13 $89

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$74,749

Medicare's payments for the services billed

Medicare patients

181

Average age 72

Services billed

1,037

104 women, 77 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 38%
Diabetes 37%
Chronic kidney disease 34%
Depression 30%
COPD 20%
Atrial fibrillation 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

172 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record